Related Experiment Videos
DNA-based selection and screening of peptide ligands
F Bartoli1, M Nuzzo, L Urbanelli
1Istituto di Ricerche di Biologia Molecolare P. Angeletti, Pomezia (Roma), Italy.
Nature Biotechnology
|November 27, 1998
Summary
This study enhanced phage display technology by adding a DNA selection step. This improved the identification of specific ligands for hepatitis C virus (HCV) antibodies, showing diagnostic potential.
Area of Science:
- Biotechnology
- Molecular Biology
- Immunology
Background:
- Phage display technology links displayed ligands to encoding DNA for rapid gene selection.
- Current methods may require improvement in specificity and sensitivity for complex biological mixtures.
Purpose of the Study:
- To enhance phage display by incorporating a DNA selection step.
- To improve the specificity and sensitivity of identifying ligands for specific antibodies in complex samples.
- To select ligands for hepatitis C virus (HCV) antibodies with diagnostic potential.
Main Methods:
- Phage display selection of a random peptide library against serum HCV antibodies.
- Incorporation of an additional DNA hybridization screening step.
- Panning and screening of displayed ligands and their encoding DNA.
Main Results:
- Successful identification of ligands for HCV antibodies present in serum.
- The combined phage display and DNA selection strategy significantly increased specificity and sensitivity.
- A specific HCV antibody ligand with diagnostic potential was selected.
Conclusions:
- Integrating DNA selection with phage display enhances ligand identification for antibodies.
- This improved methodology holds promise for developing diagnostic tools for viral infections like HCV.
- The selected ligand demonstrates potential for clinical diagnostic applications.